National Institutes of Health
Federal agency · 821 grants in this directory · 721 currently open · page 2 of 17
The National Institutes of Health is a United States federal agency that administers research and development funding. It supports health and medical research across areas including oncology, infectious diseases, aging, cognitive health, autoimmune conditions, and complementary interventions, as well as the development of diagnostic and therapeutic devices. Applicants include educational institutions, nonprofits, small businesses, tribal governments, and individuals pursuing fellowships or workforce training opportunities.
Open grants (50)
- Novel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs (P20 Clinical Trial Optional)Funding amount not specified · Closes October 2, 2026
- Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)Up to $2M · Closes October 2, 2026
- NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)Funding amount not specified · Closes October 3, 2026
- Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required)Funding amount not specified · Closes October 6, 2026
- Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)Up to $300K · Closes October 9, 2026
- Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)Funding amount not specified · Closes October 9, 2026
- Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)Up to $1M · Closes October 9, 2026
- Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)Funding amount not specified · Closes October 11, 2026
- NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)Funding amount not specified · Closes October 14, 2026
- Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed)Up to $500K · Closes October 14, 2026
- Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)Funding amount not specified · Closes October 14, 2026
- Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)Funding amount not specified · Closes October 14, 2026
- NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)Funding amount not specified · Closes October 14, 2026
- Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)Up to $250K · Closes October 14, 2026
- Advancing Research on Empirically-Supported Interventions for Older Adults Living with Serious Mental Illness (SMI) (R01 Clinical Trial Optional)Funding amount not specified · Closes October 15, 2026
- Maximizing the Scientific Value of Data Generated by the Environmental influences on Child Health Outcomes (ECHO) Program: Dissertation Grant (R36 - Clinical Trial Not Allowed)Funding amount not specified · Closes October 15, 2026
- CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)Up to $300K · Closes October 16, 2026
- Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)Up to $50K · Closes October 19, 2026
- Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)$50K – $600K · Closes October 19, 2026
- Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)$50K – $600K · Closes October 19, 2026
- Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed)Funding amount not specified · Closes October 19, 2026
- Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)Funding amount not specified · Closes October 19, 2026
- PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)Funding amount not specified · Closes October 19, 2026
- Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)Up to $750K · Closes October 20, 2026
- Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required)Funding amount not specified · Closes October 22, 2026
- Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)Funding amount not specified · Closes October 30, 2026
- GREGoRi Technology Integration Center (U01, Clinical Trials Optional)Up to $2.2M · Closes October 30, 2026
- GREGoRi Innovation Projects (U01 Clinical Trial Optional)$3 – $500K · Closes October 30, 2026
- GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)Up to $1.2M · Closes October 30, 2026
- Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)Funding amount not specified · Closes November 2, 2026
- Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)Funding amount not specified · Closes November 2, 2026
- Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)Funding amount not specified · Closes November 5, 2026
- Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)Funding amount not specified · Closes November 6, 2026
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)Up to $350K · Closes November 6, 2026
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)Funding amount not specified · Closes November 9, 2026
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)Funding amount not specified · Closes November 9, 2026
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)Funding amount not specified · Closes November 10, 2026
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)Up to $300K · Closes November 10, 2026
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)Funding amount not specified · Closes November 10, 2026
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)Funding amount not specified · Closes November 10, 2026
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)Up to $150K · Closes November 10, 2026
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)Funding amount not specified · Closes November 10, 2026
- NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)Up to $350K · Closes November 13, 2026
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)Up to $750K · Closes November 13, 2026
- NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)Up to $1M · Closes November 13, 2026
- NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)Funding amount not specified · Closes November 13, 2026
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)Up to $50K · Closes November 16, 2026
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)Up to $200K · Closes November 17, 2026
- Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)Funding amount not specified · Closes November 17, 2026
- NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)Up to $350K · Closes November 17, 2026
GrantRegister provides information, not advice. Eligibility requirements and deadlines are set by the funder and can change without notice. Confirm eligibility, deadlines, and requirements with National Institutes of Health before applying.